[DPHARMA] QoQ Quarter Result on 30-Sep-2019 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
29-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- 6.78%
YoY- 20.94%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 143,331 158,713 137,755 142,855 145,466 150,386 115,634 15.40%
PBT 19,391 17,727 13,939 19,768 18,316 18,786 17,658 6.44%
Tax -4,662 -4,166 -1,906 -4,909 -4,400 -4,321 -3,289 26.21%
NP 14,729 13,561 12,033 14,859 13,916 14,465 14,369 1.66%
-
NP to SH 14,729 13,561 12,033 14,859 13,916 14,465 14,369 1.66%
-
Tax Rate 24.04% 23.50% 13.67% 24.83% 24.02% 23.00% 18.63% -
Total Cost 128,602 145,152 125,722 127,996 131,550 135,921 101,265 17.28%
-
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 3,421 - 34,114 - 6,618 - 26,475 -74.47%
Div Payout % 23.23% - 283.51% - 47.56% - 184.25% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
NOSH 684,383 684,383 684,383 680,106 661,881 661,881 661,881 2.25%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 10.28% 8.54% 8.74% 10.40% 9.57% 9.62% 12.43% -
ROE 2.53% 2.51% 2.29% 2.94% 2.77% 2.91% 2.97% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 20.94 23.19 20.19 21.18 21.98 22.72 17.47 12.85%
EPS 2.15 1.98 1.76 2.20 2.07 2.19 2.17 -0.61%
DPS 0.50 0.00 5.00 0.00 1.00 0.00 4.00 -75.03%
NAPS 0.85 0.79 0.77 0.75 0.76 0.75 0.73 10.68%
Adjusted Per Share Value based on latest NOSH - 680,106
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 14.90 16.50 14.32 14.85 15.12 15.63 12.02 15.41%
EPS 1.53 1.41 1.25 1.54 1.45 1.50 1.49 1.78%
DPS 0.36 0.00 3.55 0.00 0.69 0.00 2.75 -74.25%
NAPS 0.6047 0.5621 0.5461 0.5259 0.5229 0.5161 0.5023 13.17%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 1.62 1.39 1.42 1.40 1.37 1.28 0.95 -
P/RPS 7.74 5.99 7.03 6.61 6.23 5.63 5.44 26.52%
P/EPS 75.27 70.15 80.52 63.56 65.16 58.57 43.76 43.60%
EY 1.33 1.43 1.24 1.57 1.53 1.71 2.29 -30.41%
DY 0.31 0.00 3.52 0.00 0.73 0.00 4.21 -82.46%
P/NAPS 1.91 1.76 1.84 1.87 1.80 1.71 1.30 29.26%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 13/08/20 18/05/20 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 -
Price 3.15 1.72 1.64 1.39 1.41 1.36 1.03 -
P/RPS 15.04 7.42 8.12 6.56 6.42 5.99 5.90 86.71%
P/EPS 146.36 86.80 92.99 63.10 67.06 62.23 47.45 112.04%
EY 0.68 1.15 1.08 1.58 1.49 1.61 2.11 -53.02%
DY 0.16 0.00 3.05 0.00 0.71 0.00 3.88 -88.08%
P/NAPS 3.71 2.18 2.13 1.85 1.86 1.81 1.41 90.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment